Caspase-3-Responsive Dual-Enhanced 1 H/ 19 F MRI Bimodal Probe for In Vivo Tumor Apoptosis Imaging
Analytical Chemistry · 06.05.2025 · 97 (17) · 9265-9275
DOI: 10.1021/acs.analchem.4c06853 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 22.04.2025. Verfasst von Yue Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Magnetic Resonance Spectroscopy and Imaging, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and …. Hauptthemen laut MEDLINE: Apoptosis, Caspase 3, Magnetic Resonance Imaging, Contrast Media. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of Hubei Province, National Natural Science Foundation of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
Caspase-3 (Cas-3) is a crucial cysteine protease involved in executing cell apoptosis, a process that is a hallmark of tumor cell apoptosis response to chemotherapy. Developing molecular imaging probes that specifically detect apoptotic signals during tumor treatment is considered to be one of the most important and effective strategies for reducing cancer-associated death rates and improving treatment outcomes. However, achieving a dual-enhanced bimodal probe in a single molecule remains a significant challenge. In this study, we developed a 1H/19F dual-enhanced magnetic resonance imaging (MRI) probe, CF3DEVDFFFK(Fmoc)-Gd, responsive to caspase-3 for in vivo imaging of apoptotic cells. Upon interaction with caspase-3, CF3DEVDFFFK(Fmoc)-Gd efficiently splits into two components CF3DEVD and FFFK(Fmoc)-C2-Gd, where FFFK(Fmoc)-C2-Gd subsequently self-assembles into nanofibers. This process activates both 19F MRI and 1H MRI, with longitudinal relaxivity (r1) increasing from 9.38 ± 0.22 to 23.24 ± 2.33 mM-1 s-1 at 0.5 T and turning on the 19F MRI signal due to the absence of the paramagnetic relaxation enhancement (PRE) effect. In vivo imaging results demonstrated that, after systemic administration, CF3DEVDFFFK(Fmoc)-Gd effectively accumulated in apoptotic 4T1 tumor tissues, resulting in significantly enhanced 1H MRI signals for visualization of caspase-3 activity in doxorubicin-treated apoptotic 4T1 tumor tissues, with signal intensity three times greater than that of Gd-DTPA. 19F MRI further complemented 1H MRI, with a notable recovery of the 19F MRI signal after intratumoral injection. These results confirm that CF3DEVDFFFK(Fmoc)-Gd effectively reports tumor apoptosis through combined 1H and 19F MRI, offering a promising approach for the preliminary assessment of antitumor efficacy in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Magnetic Resonance Spectroscopy and Imaging, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Science and…
- University of Chinese Academy of Sciences, Beijing 100049, P. R. China.
- School of Biomedical Engineering, Hainan University, Sanya 572019, P. R. China.
ORCID-Profile: Zhong-Xing Jiang, Xin Zhou
Förderung
- Natural Science Foundation of Hubei Province
- National Natural Science Foundation of China
- Chinese Academy of Sciences
Zitieren
APA
Zhu, Y., Zhang, L., Li, S., Luo, Y., Xiao, L., Yu, Q., Jiang, Z. X., Zhou, X., & Chen, S. (2025). Caspase-3-Responsive Dual-Enhanced 1 H/ 19 F MRI Bimodal Probe for In Vivo Tumor Apoptosis Imaging. Analytical Chemistry, 97(17), 9265-9275. https://doi.org/10.1021/acs.analchem.4c06853
Vancouver
Zhu Y, Zhang L, Li S, Luo Y, Xiao L, Yu Q, et al. Caspase-3-Responsive Dual-Enhanced 1 H/ 19 F MRI Bimodal Probe for In Vivo Tumor Apoptosis Imaging. Analytical Chemistry. 2025;97(17):9265-9275. doi:10.1021/acs.analchem.4c06853
BibTeX
@article{Zhu2025,
author = {Zhu, Yue and Zhang, Lei and Li, Sha and Luo, Yingying and Xiao, Long and Yu, Qiao and Jiang, Zhong-Xing and Zhou, Xin and Chen, Shizhen},
title = {Caspase-3-Responsive Dual-Enhanced 1 H/ 19 F MRI Bimodal Probe for In Vivo Tumor Apoptosis Imaging},
journal = {Analytical Chemistry},
year = {2025},
volume = {97},
number = {17},
pages = {9265--9275},
doi = {10.1021/acs.analchem.4c06853}
}
EUVIMED